New System Combines Diagnostic Ultrasound and Transient Elastography
In order to facilitate optimal detection and assessment of liver fibrosis and steatosis, the newly launched Hepatus 6 Diagnostic Ultrasound System offers the capabilities of real-time two-dimensional ultrasound with visual transient elastography in one device.
Offering a variety of automated tools and enhanced diagnostic functionality to aid in the diagnosis and quantification of liver fibrosis and steatosis, Minday has launched the Hepatus 6 Diagnostic Ultrasound System.
In addition to the benefits of two-dimensional (2D) and color Doppler imaging for the assessment of liver morphology, Mindray said the Hepatus 6 Diagnostic Ultrasound System provides access to visual transient elastography (ViTE) in the same device.
Automated features include quantitative analysis of liver stiffness, liver ultrasound attenuation analysis and one-click capture of 10 automated Q-scan measurements of fibrosis and steatosis within seconds, according to Mindray.
“The Hepatus 6 system provides clinicians a clear view of patient liver health and helps create a clear path forward for patients with chronic liver disease like no other system on the market today,” noted Wayne Quinn, the president of Mindray North America.
Mindray said another aspect of the Hepatus 6 Diagnostic Ultrasound System includes the ability to switch between the ViTE transducer and the curved ultrasound transducer to see greater real-time detail. The company added that an adjustable panel facilitates ergonomic workflow.
(Editor’s note: For related content, see “MRI Study Shows Higher Fibrosis Risk Among First-Degree Relatives of People with NAFLD and Advanced Fibrosis” and “Can Deep Learning Enhance Ultrasound Assessment of Hepatic Steatosis in Patients with NAFLD?”)
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
